<?xml version="1.0" encoding="ISO-8859-1"?>

<rss version="2.0">
<channel>
<title>IMULAN - PRWeb Press Release Group</title>
<link>http://www.rsspad.com/rss2/39144.xml</link>
<description>IMULAN - Powered by PRWeb and RSSPad</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
         <title>IMULAN Initiates Feline Leukemia Virus (FeLV) Study </title>
         <link>http://www.prweb.com/releases/2008/06/prweb1001644.htm</link><description>   <![CDATA[ <P>IMULAN has initiated additional clinical trials to assess the effects of the first and only approved treatment aid in the United States for feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV or Feline AIDS). (PRWeb Jun 6, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/06/prweb1001644.htm">http://www.prweb.com/releases/2008/06/prweb1001644.htm</a></P>]]>
                </description>
<pubDate>Fri, 06 Jun 2008 07:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2008/06/prweb1001644.htm</guid> </item>
<item>
         <title>IMULAN BioTherapeutics&amp;#039; ImSAIDs Demonstrate Promise for Pancreatitis</title>
         <link>http://www.prweb.com/releases/2008/05/prweb945804.htm</link><description>   <![CDATA[ <P>Canine and feline pancreatitis are disease targets for the Immune Selective Anti-Inflammatory Derivatives (ImSAIDs) from IMULAN BioTherapeutics. (PRWeb May 16, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb945804.htm">http://www.prweb.com/releases/2008/05/prweb945804.htm</a></P>]]>
                </description>
<pubDate>Fri, 16 May 2008 07:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2008/05/prweb945804.htm</guid> </item>
<item>
         <title>Feline Leukemia and Feline AIDS (FeLV-FIV) Treatment Aid Is Now Available in New 3-Pack </title>
         <link>http://www.prweb.com/releases/2008/03/prweb807834.htm</link><description>   <![CDATA[ <P>Lymphocyte T-Cell Immunomodulator (LTCI) from IMULAN BioTherapeutics, the first and only approved treatment aid in the United States for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV or Feline AIDS) infections, is now available in an affordable three-dose pack designed for new patients. (PRWeb Mar 28, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/03/prweb807834.htm">http://www.prweb.com/releases/2008/03/prweb807834.htm</a></P>]]>
                </description>
<pubDate>Fri, 28 Mar 2008 07:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2008/03/prweb807834.htm</guid> </item>
<item>
         <title>IMULAN Officially Launches Treatment for Feline Leukemia and Feline Aids (FeLV and FIV)</title>
         <link>http://www.prweb.com/releases/2008/03/prweb738484.htm</link><description>   <![CDATA[ <P>FeLV and FIV infected cats can now be treated with Lymphocyte T-Cell Immunomodulator (LTCI) from IMULAN BioTherapeutics, the first and only approved treatment aid in the United States for two of the most common fatal feline diseases. (PRWeb Mar 5, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/03/prweb738484.htm">http://www.prweb.com/releases/2008/03/prweb738484.htm</a></P>]]>
                </description>
<pubDate>Wed, 05 Mar 2008 08:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2008/03/prweb738484.htm</guid> </item>
</channel>
</rss>